Carrier advocacy coverage letter for prostate artery embolization for the treatment of BPH

The prostatic artery embolization (PAE) evidence-based letter was written by IR physicians that are members of SIR's Carrier Advocacy Workgroup. The letter is intended to help IRs during the authorization, appeal and denial process with any payor denying this service. This letter was last reviewed and updated on September 22, 2025.

Policy coverage topic: prostate artery embolization for the treatment of benign prostatic hyperplasia (BPH) treatments.

A subscription model applies to this product. The text, graphics and information are of a general nature; it is not a substitute for obtaining medical advice. We may update the documents at any time without prior notice.

A patient appeal letter is available for this procedure. These patient-facing resources are designed to help individuals whose insurance coverage has been denied explain the medical necessity of the recommended treatment and formally request reconsideration from their payer.

Physicians may choose to share this letter with their patients to support the appeals process.